ArticleAmerican journal of cancer research2019
PDE3A inhibitor anagrelide activates death signaling pathway genes and synergizes with cell death-inducing cytokines to selectively inhibit cancer cell growth.
Ran An et al.PubMed ↗Full text ↗
No numbers read from the abstract.
22 papers cite it
this papercites it